SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-020840
Filing Date
2020-11-09
Accepted
2020-11-09 16:59:38
Documents
72
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1453471
2 ex31-1.htm EX-31.1 10378
3 ex31-2.htm EX-31.2 10300
4 ex32-1.htm EX-32.1 9397
  Complete submission text file 0001493152-20-020840.txt   7348127

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE mbii-20200930.xsd EX-101.SCH 62712
6 XBRL CALCULATION FILE mbii-20200930_cal.xml EX-101.CAL 67018
7 XBRL DEFINITION FILE mbii-20200930_def.xml EX-101.DEF 242789
8 XBRL LABEL FILE mbii-20200930_lab.xml EX-101.LAB 469043
9 XBRL PRESENTATION FILE mbii-20200930_pre.xml EX-101.PRE 361741
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1344461
Mailing Address 1540 DREW AVENUE DAVIS CA 95618
Business Address 1540 DREW AVENUE DAVIS CA 95618 530-750-2800
MARRONE BIO INNOVATIONS INC (Filer) CIK: 0001441693 (see all company filings)

IRS No.: 205137161 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36030 | Film No.: 201298568
SIC: 2870 Agricultural Chemicals